Neuren Pharmaceuticals | NEU - Ordinary Share Capital


Neuren Pharmaceuticals reported AUD165.27M in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Genetic Signatures AUD 127.64M 8.22M Dec/2024
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Organon & Co USD 259.98M 18K Sep/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Starpharma Holdings AUD 240.75M 0 Dec/2024
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Telix Pharmaceuticals AUD 587.41M 141.14M Jun/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025